https://www.selleckchem.com/pr....oducts/Nanchangmycin
Our findings provide new evidence to support the important role of KIF7 in the pathogenesis of lung cancer and suggests new therapeutic targets. Here, we demonstrated for the first time that E6 but not E7 inhibits the antitumor activity of LKB1 in lung cancer cells by downregulating the expression of KIF7. Our findings provide new evidence to support the important role of KIF7 in the pathogenesis of lung cancer and suggests new therapeutic targets. To determine the prevalence of fundus pathology in metropolitan Australian EDs util
Curtir
Comentario
Compartilhar
